Imetelstat
Geron Corporation
['mds']
geron's imetelstat shows positive results in imerge phase 3 trial for lower risk mds patients, supporting nda submission in june 2023. $gern #biopharma #asco #positive 
Real-time news analysis & sentiment scoring for the stocks in the Nasdaq100
Powered by @streetbeat_com of @SP500Tracker
Disclosure: https://t.co/ixCFGXlG3M